Literature DB >> 22188017

Predominant recurrence polarity among 928 adult international bipolar I disorder patients.

R J Baldessarini1, J Undurraga, G H Vázquez, L Tondo, P Salvatore, K Ha, H-M K Khalsa, B Lepri, T H Ha, J S Chang, M Tohen, E Vieta.   

Abstract

OBJECTIVE: To test the hypothesis that patients with bipolar disorder (BPD) differ demographically and clinically within subgroups based on the predominant-polarity of major recurrences.
METHOD: We tested factors for association with predominantly (≥2 : 1) depressive vs. mania-like episodes with 928 DSM-IV type-I BPD subjects from five international sites.
RESULTS: Factors preliminarily associated with predominant-depression included: electroconvulsive treatment, longer latency-to-BPD diagnosis, first episode depressive or mixed, more suicide attempts, more Axis-II comorbidity, ever having mixed-states, ever married, and female sex. Predominant-mania was associated with: initial manic or psychotic episodes, more drug abuse, more education, and more family psychiatric history. Of the 47.3% of subjects without polarity-predominance, risks for all factors considered were intermediate. Expanding the definition of polarity-predominance to ≥51% added little, but shifting mixed-states to 'predominant-depression' increased risk of suicidal acts from 2.4- to 4.5-fold excess over predominant-mania-hypomania, and suicidal risk was associated continuously with increasing proportions of depressive or mixed episodes.
CONCLUSION: Subtyping by predominant-polarity yielded predictive associations, including the polarity of first episodes and risk of suicide attempts. Such subtyping may contribute to improve planning of clinical care and to biological studies of BPD.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 22188017     DOI: 10.1111/j.1600-0447.2011.01818.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  15 in total

1.  International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder.

Authors:  Ayal Schaffer; Erkki T Isometsä; Leonardo Tondo; Doris H Moreno; Gustavo Turecki; Catherine Reis; Frederick Cassidy; Mark Sinyor; Jean-Michel Azorin; Lars Vedel Kessing; Kyooseob Ha; Tina Goldstein; Abraham Weizman; Annette Beautrais; Yuan-Hwa Chou; Nancy Diazgranados; Anthony J Levitt; Carlos A Zarate; Zoltán Rihmer; Lakshmi N Yatham
Journal:  Bipolar Disord       Date:  2014-10-20       Impact factor: 6.744

Review 2.  Options for pharmacological treatment of refractory bipolar depression.

Authors:  Leonardo Tondo; Gustavo H Vázquez; Ross J Baldessarini
Journal:  Curr Psychiatry Rep       Date:  2014-02       Impact factor: 5.285

3.  The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.

Authors:  Isabella Pacchiarotti; David J Bond; Ross J Baldessarini; Willem A Nolen; Heinz Grunze; Rasmus W Licht; Robert M Post; Michael Berk; Guy M Goodwin; Gary S Sachs; Leonardo Tondo; Robert L Findling; Eric A Youngstrom; Mauricio Tohen; Juan Undurraga; Ana González-Pinto; Joseph F Goldberg; Ayşegül Yildiz; Lori L Altshuler; Joseph R Calabrese; Philip B Mitchell; Michael E Thase; Athanasios Koukopoulos; Francesc Colom; Mark A Frye; Gin S Malhi; Konstantinos N Fountoulakis; Gustavo Vázquez; Roy H Perlis; Terence A Ketter; Frederick Cassidy; Hagop Akiskal; Jean-Michel Azorin; Marc Valentí; Diego Hidalgo Mazzei; Beny Lafer; Tadafumi Kato; Lorenzo Mazzarini; Anabel Martínez-Aran; Gordon Parker; Daniel Souery; Ayşegül Ozerdem; Susan L McElroy; Paolo Girardi; Michael Bauer; Lakshmi N Yatham; Carlos A Zarate; Andrew A Nierenberg; Boris Birmaher; Shigenobu Kanba; Rif S El-Mallakh; Alessandro Serretti; Zoltan Rihmer; Allan H Young; Georgios D Kotzalidis; Glenda M MacQueen; Charles L Bowden; S Nassir Ghaemi; Carlos Lopez-Jaramillo; Janusz Rybakowski; Kyooseob Ha; Giulio Perugi; Siegfried Kasper; Jay D Amsterdam; Robert M Hirschfeld; Flávio Kapczinski; Eduard Vieta
Journal:  Am J Psychiatry       Date:  2013-11       Impact factor: 18.112

Review 4.  Suicidal behaviour in mood disorders--who, when, and why?

Authors:  Erkki Isometsä
Journal:  Can J Psychiatry       Date:  2014-03       Impact factor: 4.356

Review 5.  Bipolar Disorder and Suicide: a Review.

Authors:  Jacob N Miller; Donald W Black
Journal:  Curr Psychiatry Rep       Date:  2020-01-18       Impact factor: 5.285

6.  Predominant polarity in bipolar disorder and validation of the polarity index in a German sample.

Authors:  Julia Volkert; Kathrin C Zierhut; Miriam A Schiele; Martina Wenzel; Juliane Kopf; Sarah Kittel-Schneider; Andreas Reif
Journal:  BMC Psychiatry       Date:  2014-11-22       Impact factor: 3.630

Review 7.  Treatment implications of predominant polarity and the polarity index: a comprehensive review.

Authors:  Andre F Carvalho; João Quevedo; Roger S McIntyre; Márcio G Soeiro-de-Souza; Konstantinos N Fountoulakis; Michael Berk; Thomas N Hyphantis; Eduard Vieta
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

Review 8.  The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines.

Authors:  Konstantinos N Fountoulakis; Allan Young; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Pierre Blier; Hans Jurgen Moeller; Siegfried Kasper
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

9.  Relating the bipolar spectrum to dysregulation of behavioural activation: a perspective from dynamical modelling.

Authors:  Arno Steinacher; Kim A Wright
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

10.  Illness stage and predominant polarity in bipolar disorder: Correlation with burden of illness and moderation of treatment outcome.

Authors:  Masoud Kamali; Samantha Pegg; Jessica A Janos; William V Bobo; Benjamin Brody; Keming Gao; Terence A Ketter; Susan L McElroy; Melvin G McInnis; Dustin J Rabideau; Noreen A Reilly-Harrington; Richard C Shelton; Louisa G Sylvia; Mauricio Tohen; Andrew Nierenberg
Journal:  J Psychiatr Res       Date:  2021-06-02       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.